Loading portfolio…
Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | Alphabet Inc-Cl C | $26.2M | 91200 | 15.60% |
| 2 | Apollo Global Management, Inc. | $25.1M | 225000 | 14.95% |
| 3 | Syndax Pharmaceutical, Inc. | $9.9M | 422000 | 5.88% |
| 4 | Bridgebio Pharma, Inc. | $6.7M | 90000 | 3.98% |
| 5 | Protagonist Therapeutics, Inc | $6.6M | 63000 | 3.96% |
| 6 | Xeris Biopharma Holdings, Inc. | $6.1M | 1060000 | 3.67% |
| 7 | JPMorgan Chase & Co. | $5.7M | 19477 | 3.42% |
| 8 | Iovance Biotherapeutics, Inc. | $5.6M | 1600000 | 3.35% |
| 9 | LPL Financial Holdings Inc. | $5.0M | 16500 | 2.96% |
| 10 | Janus Henderson AAA CLO ETF | $4.7M | 93528 | 2.81% |
| 11 | Alkermes PLC | $4.2M | 120000 | 2.53% |
| 12 | Travere Therapeutics, Inc. | $4.2M | 140633 | 2.49% |
| 13 | Cogent Biosciences Inc. | $4.0M | 104000 | 2.39% |
| 14 | Viridian Therapeutics, Inc. | $3.5M | 181000 | 2.11% |
| 15 | Agios Pharmaceutical, Inc. | $3.1M | 93058 | 1.88% |
| 16 | Relmada Therapeutics, Inc. | $3.1M | 439300 | 1.82% |
| 17 | TG Therapeutics, Inc. | $3.0M | 90001 | 1.78% |
| 18 | Catalyst Pharmaceuticals, Inc. | $3.0M | 120000 | 1.77% |
| 19 | Arcellx Inc | $2.2M | 19433 | 1.33% |
| 20 | SPDR S&P Biotech ETF | $1.9M | 15000 | 1.14% |
| 21 | AllianceBernstein Holding L.P. | $1.8M | 48000 | 1.07% |
| 22 | Arcus Biosciences, Inc. | $1.8M | 81241 | 1.05% |
| 23 | DocGo, Inc. | $1.7M | 2670850 | 1.00% |
| 24 | Cybin Inc | $1.7M | 350000 | 1.00% |
| 25 | Cytokinetics, Incorporated | $1.6M | 23644 | 0.93% |
| 26 | Centessa Pharmaceuticals PLC | $1.5M | 39000 | 0.92% |
| 27 | AtriCure, Inc. | $1.5M | 51400 | 0.87% |
| 28 | Ardelyx, Inc. | $1.2M | 207000 | 0.74% |
| 29 | The Panagram BBB-B CLO ETF | $1.2M | 47807 | 0.73% |
| 30 | Rezolute, Inc. | $1.1M | 370000 | 0.67% |
| 31 | Orchestra Biomed Holdings, Inc. | $1.1M | 253651 | 0.64% |
| 32 | Madrigal Pharmaaceuticals, Inc. | $1.0M | 2000 | 0.62% |
| 33 | Vera Therapeutics, Inc. | $1.0M | 26000 | 0.62% |
| 34 | Connect Biopharma Holdings Limited | $1.0M | 387835 | 0.61% |
| 35 | Johnson & Johnson | $978K | 4000 | 0.58% |
| 36 | iShares Biotechnology ETF | $929K | 5500 | 0.55% |
| 37 | Pfizer Inc. | $908K | 32337 | 0.54% |
| 38 | Bristol-Myers Squibb Company | $826K | 13622 | 0.49% |
| 39 | Canadian Natural Resources Limited | $819K | 16800 | 0.49% |
| 40 | Biogen Inc. | $733K | 4000 | 0.44% |
| 41 | Ultragenyx Pharmaceutical Inc. | $693K | 33069 | 0.41% |
| 42 | Apple Inc. | $633K | 2494 | 0.38% |
| 43 | Microsoft Corporation | $592K | 1600 | 0.35% |
| 44 | Verastem Inc. | $551K | 104000 | 0.33% |
| 45 | ADMA Biologics, Inc. | $542K | 60200 | 0.32% |
| 46 | International Business Machines | $519K | 2142 | 0.31% |
| 47 | Biohaven Pharmaceutical Holding Co. Ltd | $514K | 60720 | 0.31% |
| 48 | Pelthos Therapeutics, Inc. | $443K | 21073 | 0.26% |
| 49 | Kura Oncology, Inc. | $429K | 52767 | 0.26% |
| 50 | Evolus, Inc. | $408K | 99338 | 0.24% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.